The Technical AnalystExchange: JKT Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
PT Phapros, Tbk Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% IDR498.00
America/New_York / 3 mai 2024 @ 05:05
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 418 320 mill |
| EPS: | 7.02 |
| P/E: | 70.94 |
| Earnings Date: | Mar 31, 2023 |
| SharesOutstanding: | 840.00 mill |
| Avg Daily Volume: | 0.632 mill |
| RATING 2024-05-03 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.08x |
| Company: PE 70.94 | sector: PE 65.62 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 4.43x |
| Company: PE 70.94 | industry: PE 16.03 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
IDR597.53 (19.99%) IDR99.53 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
IDR 470.69 - 525.31 ( +/- 5.48%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | IDR498.00 (0.00% ) |
| Volume | 0.156 mill |
| Avg. Vol. | 0.632 mill |
| % of Avg. Vol | 24.73 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PEHA.JK
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
PEHA.JK
PT Phapros, Tbk operates in the pharmaceutical and health care industry in Indonesia. The company operates through Over the Counter (OTC), Ethical, Generic Drugs Bearing, and Toll Manufacturing segments. It offers OTC drugs, including Antimo Anak, Livron B Plek, Noza, Hemorogard, Bioron, and others. The company also provides generic drug products for government institutions and hospitals, as well as produces drugs for other pharmaceutical industries; and offers medical devices. PT Phapros, Tbk also exports its products internationally. The company was founded in 1954 and is headquartered in Jakarta, Indonesia. PT Phapros, Tbk operates as a subsidiary of PT Kimia Farma (Persero) Tbk.